Jackson Grant Investment Advisers’s AstraZeneca AZN Stock Holding History

Jackson Grant Investment Advisers’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1K	Hold	134	–	–	0.01%	242
2026 Q1	$26K	Sell	134 -1	-0.7%	-$193	0.01%	244
2025 Q4	$24.7K	Hold	135	–	–	0.01%	245
2025 Q3	$20.6K	Buy	135 +1	+0.7%	+$151	0.01%	250
2025 Q2	$18.7K	Hold	134	–	–	0.01%	236
2025 Q1	$19.6K	Buy	134 +2	+2%	+$289	0.01%	225
2024 Q4	$17.3K	Hold	132	–	–	0.01%	237
2024 Q3	$20.5K	Buy	132 +1	+0.8%	+$161	0.01%	231
2024 Q2	$20.4K	Buy	+131	New	+$19.7K	0.01%	231
2023 Q2	–	Sell	-384	Closed	-$53.3K	–	421
2023 Q1	$53.3K	Hold	384	–	–	0.03%	179
2022 Q4	$52.1K	Hold	384	–	–	0.03%	178
2022 Q3	$42K	Hold	384	–	–	0.02%	188
2022 Q2	$51K	Hold	384	–	–	0.03%	177
2022 Q1	$51K	Hold	384	–	–	0.02%	198
2021 Q4	$45K	Hold	384	–	–	0.02%	176
2021 Q3	$46K	Hold	384	–	–	0.02%	211
2021 Q2	$46K	Hold	384	–	–	0.02%	211
2021 Q1	$38K	Hold	384	–	–	0.02%	223
2020 Q4	$38K	Buy	+384	New	+$40.7K	0.02%	206
2019 Q1	–	Sell	-20	Closed	-$2K	–	230
2018 Q4	$2K	Buy	+20	New	+$1.56K	﹤0.01%	229

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ISS

Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Jackson Grant Investment Advisers's AZN Position: Q2 2026 in Review

Jackson Grant Investment Advisers held its AstraZeneca (AZN) position steady in Q2 2026 at 134 shares worth $25.1K. The position accounts for 0.01% of the portfolio, ranked #242.

Jackson Grant Investment Advisers first reported a position in AZN in Q4 2018 and has held it in 20 quarters since. The position peaked at $53.3K in Q1 2023. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Jackson Grant Investment Advisers held 134 shares of AstraZeneca worth $25.1K as of Q2 2026.
Jackson Grant Investment Advisers left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.01% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #242 holding.
Jackson Grant Investment Advisers first reported a position in AstraZeneca in Q4 2018 and has held it in 20 quarters since.
Jackson Grant Investment Advisers's AstraZeneca position peaked at $53.3K in Q1 2023.
655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.